Skip to main content
    E

    Encompass Health Corp (EHC)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $142.17
    +1.18 (+0.84%)

    Market Cap: $13.83B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Encompass Health Corp (EHC) Financials: Revenue, Profit and Cash Flow

    Updated Oct 28, 2026. Financial statements from company filings, amounts in US dollars.

    Encompass Health reported revenue of $5.94B for the fiscal year ended Dec 31, 2025, up 10.5% from the year before. That year, net income was $759.10M with a net margin of 12.8%, operating cash flow was $1.18B and free cash flow was $439.20M. The quarter ended Sep 30, 2026 had revenue of $1.61B and net income of $203.60M.

    Revenue and Margins

    The operating margin was 17.7% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $3.64B, a compound annual rate of 5.6%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$5.94B+10.5%46.5%17.7%12.8%
    Dec 2024$5.37B+11.9%44.9%16.1%11.1%
    Dec 2023$4.80B+10.4%44.7%15.2%9.6%
    Dec 2022$4.35B+8.3%43.7%14.5%8.4%
    Dec 2021$4.01B+12.6%45.5%16.4%12.9%
    Dec 2020$3.57B-22.6%44.9%14.8%10.3%
    Dec 2019$4.61B+7.7%42.3%15.0%9.7%
    Dec 2018$4.28B+9.3%45.0%14.7%6.8%
    Dec 2017$3.91B+7.4%45.0%16.6%6.9%
    Dec 2016$3.64BN/A45.5%17.8%6.8%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 27.2% from the year before. In the quarter ended Sep 2026, net income rose 16.6% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$5.94B$5.37B$4.80B$4.35B$4.01B$3.57B$4.61B$4.28B$3.91B$3.64B
    Cost of revenue$3.17B$2.96B$2.66B$2.45B$2.19B$1.97B$2.66B$2.35B$2.15B$1.99B
    Gross profit$2.76B$2.41B$2.14B$1.90B$1.83B$1.60B$1.95B$1.92B$1.76B$1.66B
    Operating income$1.05B$864.50M$731.80M$630.20M$659.40M$527.60M$692.50M$629.60M$649.40M$648.80M
    Net income$759.10M$596.60M$463.00M$365.90M$517.20M$368.80M$445.80M$292.30M$271.10M$247.60M
    EBITDA$1.41B$1.19B$1.03B$878.30M$894.30M$746.20M$946.20M$835.50M$846.00M$838.10M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$1.61B$1.60B$1.59B$1.54B$1.48B$1.46B$1.46B$1.41B$1.35B$1.30B$1.32B$1.25B
    Gross profit$753.80M$762.40M$753.30M$729.00M$677.80M$675.30M$678.20M$633.50M$604.50M$586.50M$590.40M$556.50M
    Operating income$288.00M$288.40M$301.60M$283.40M$243.60M$259.10M$267.00M$232.30M$209.10M$215.60M$207.50M$189.90M
    Net income$203.60M$207.40M$248.20M$203.10M$174.60M$184.90M$196.50M$164.20M$147.10M$146.50M$138.80M$119.10M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $2.49B exceeded cash and equivalents by $2.42B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$7.09B$6.53B$6.10B$5.64B$6.86B$6.45B$6.08B$5.17B$2.09B$4.68B
    Current assets$905.90M$886.90M$841.80M$717.20M$921.40M$948.60M$755.80M$662.10M$116.80M$654.50M
    Cash and equivalents$72.20M$85.40M$69.10M$21.80M$49.40M$224.00M$94.80M$69.20M$54.40M$40.50M
    Total liabilities$3.81B$3.69B$3.81B$3.77B$4.47B$4.44B$4.15B$3.36B$0$3.61B
    Short-term debt$43.60M$138.60M$24.80M$25.20M$37.80M$38.30M$39.30M$35.80M$32.30M$37.10M
    Long-term debt$2.45B$2.36B$2.69B$2.74B$3.24B$3.25B$3.02B$2.48B$2.55B$2.98B
    Shareholder equity$0$2.07B$1.65B$1.31B$1.91B$1.59B$1.35B$1.28B$0$735.90M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$7.57B$7.46B$7.31B$7.09B$6.87B$6.79B$6.64B$6.53B$6.46B$6.39B$6.23B$6.10B
    Total liabilities$4.01B$4.00B$3.95B$3.81B$3.68B$3.70B$3.70B$3.69B$3.73B$3.86B$3.83B$3.81B
    Cash and equivalents$76.20M$107.70M$110.50M$102.90M$48.70M$99.10M$95.80M$85.40M$147.80M$154.40M$134.40M$104.20M
    Shareholder equity$0$0$0$2.44B$0$0$0$2.07B$0$0$0$1.65B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 37.2% of operating cash flow. Dividends and share repurchases together came to 86.8% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$1.18B$1.00B$850.80M$705.80M$715.80M$704.70M$635.30M$762.40M$658.30M$640.20M
    Capital expenditures$736.40M$642.50M$583.10M$584.10M$545.70M$401.10M$385.40M$270.50M$245.00M$202.90M
    Free cash flow$439.20M$360.30M$267.70M$121.70M$170.10M$303.60M$249.90M$491.90M$413.30M$437.30M
    Dividends paid$223.20M$187.80M$175.10M$195.60M$213.30M$345.00M$351.40M$241.30M$143.40M$148.70M
    Share repurchases$158.00M$31.10M$0$0N/A$6.10M$45.90M$0$38.10M$65.60M
    Investing cash flow-$764.60M-$653.30M-$602.80M-$627.00M-$666.30M-$407.50M-$657.40M-$424.50M-$283.00M-$229.90M
    Financing cash flow-$431.20M-$330.60M-$197.20M-$145.70M-$240.10M-$145.90M$48.20M-$321.20M-$359.90M-$416.40M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$362.00M$282.60M$313.10M$346.00M$270.80M$270.20M$288.60M$278.80M$267.80M$217.40M$238.80M$201.00M
    Capital expenditures$234.50M$220.30M$162.40M$229.30M$187.10M$156.90M$163.10M$198.70M$147.50M$156.90M$139.40M$211.70M
    Free cash flow$127.50M$62.30M$150.70M$116.70M$83.70M$113.30M$125.50M$80.10M$120.30M$60.50M$99.40M-$10.70M
    Last 12 quarters

    Frequently Asked Questions About EHC

    What is Encompass Health's annual revenue?

    Encompass Health reported revenue of $5.94B for the fiscal year ended Dec 31, 2025.

    How fast is Encompass Health's revenue growing?

    Revenue was up 10.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 10.9%.

    Is Encompass Health profitable?

    Yes. Encompass Health reported net income of $759.10M for the fiscal year ended Dec 31, 2025, with a net margin of 12.8%.

    How much free cash flow does EHC generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $1.18B minus capital expenditures of $736.40M produced free cash flow of $439.20M.

    How much debt does Encompass Health have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $2.45B, short-term debt of $43.60M and cash and equivalents of $72.20M.